Next Article in Journal
Combined Biological and Chemical/Physicochemical Pretreatment Methods of Lignocellulosic Biomass for Bioethanol and Biomethane Energy Production—A Review
Previous Article in Journal
Selected Antimicrobial Peptides Inhibit In Vitro Growth of Campylobacter spp.
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Applied Microbiology
Volume 2
Issue 4
10.3390/applmicrobiol2040054
applmicrobiol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Photocatalytic Inactivation of Viruses and Prions: Multilevel Approach with Other Disinfectants

by
Takashi Onodera
1,2,*,
Katsuaki Sugiura
1,
Makoto Haritani
1,
Tohru Suzuki
3,
Morikazu Imamura
4,
Yoshifumi Iwamaru
5,
Yasuhisa Ano
6,
Hiroyuki Nakayama
6,7 and
Akikazu Sakudo
8
1
Laboratory of Environmental Science for Sustainable Development, Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
2
Research Center for Food Safety, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
3
National Institute of Animal Health, Sapporo 052-0045, Japan
4
Faculty of Medicine, University of Miyazaki, Kiyotake-cho 889-1692, Japan
5
National Institute of Animal Health, Tsukuba 305-1102, Japan
6
Department of Veterinary Medical Sciences, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
7
Animal Medical Center, 3-60-7 Sendagaya, Shibuya-Ku, Tokyo 151-0051, Japan
8
School of Veterinary Medicine, Okayama University of Science, Imabari 794-8555, Japan
*
Author to whom correspondence should be addressed.
Appl. Microbiol. 2022, 2(4), 701-715; https://doi.org/10.3390/applmicrobiol2040054
Submission received: 15 August 2022 / Revised: 13 September 2022 / Accepted: 20 September 2022 / Published: 23 September 2022
Browse Figures
Review Reports Versions Notes

Abstract

:
Ag, Cu, Zn, Ti, and Au nanoparticles show enhanced photocatalytic properties. Efficient indoor disinfection strategies are imperative to manage the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Virucidal agents, such as ethanol, sodium hypochlorite, 222-nm UV light, and electrolyzed water inactivate SARS-CoV-2 in indoor environments. Tungsten trioxide (WO3) photocatalyst and visible light disinfect abiotic surfaces against SARS-CoV-2. The titanium dioxide (TiO2)/UV system inactivates SARS-CoV-2 in aerosols and on deliberately contaminated TiO2-coated glass slide surfaces in photocatalytic chambers, wherein 405-nm UV light treatment for 20 min sterilizes the environment and generates reactive oxygen species (ROS) that inactivate the virus by targeting S and envelope proteins and viral RNA. Mesoscopic calcium bicarbonate solution (CAC-717) inactivates pathogens, such as prions, influenza virus, SARS-CoV-2, and noroviruses, in fluids; it presumably acts similarly on human and animal skin. The molecular complexity of cementitious materials promotes the photocatalysis of microorganisms. In combination, the two methods can reduce the pathogen load in the environment. As photocatalysts and CAC-717 are potent disinfectants for prions, disinfectants against prionoids could be developed by combining photocatalysis, gas plasma methodology, and CAC-717 treatment, especially for surgical devices and instruments.

1. Introduction

Titanium dioxide (TiO2), tungsten trioxide (WO3), and graphene possess photocatalytic properties [1]. Ultraviolet (UV) rays induce the generation of hydroxy radicals, hydrogen peroxide, or reactive oxygen species (ROS). These biologically reactive species induce microbiocidal effects against a variety of organisms, such as bacteria, fungi, and viruses [2]. Recently, visible light has been reported to induce photocatalysis [3,4,5]. It can reduce the abundance of Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and bacteriophages on abiotic surfaces to levels below 10−2 to 10−6 cells per mL.
A complex salt consisting of silver iodide and benzalkonium chloride reportedly induced photocatalytic effects in commercially available painting solutions [6] and exhibited microbiocidal properties in the environment. The following three mechanisms are involved in viral inactivation using TiO2 complexes: structural disintegration of viruses, toxicity to metal ions among metal-containing photocatalysts, and chemical oxidation of ROS generated over the photocatalysts [7]. The total photocatalytic virucidal effect is much stronger than the original toxicity of metal ions, as shown by comparing the results in an environment without lighting. Photocatalyst-induced ultrastructural destruction in adenoviruses has been demonstrated using transmission electron microscopy [8].
Several nanomaterials such as those of Ag [9,10], Cu [11,12], Zn [13], Ti [14], and Au [15] have been used for developing photocatalysts. The Japanese government is continuing to pursue a more effective photocatalyst to manage the global pandemic. Some of these photocatalysts exhibit stronger virucidal effects than the original materials, which could help in developing new methods to prevent the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [16,17]. Although the detailed mechanisms underlying the function of these nanoparticles are not well-studied, the generation of ROS could be the main mechanism responsible for their virucidal effects. Recently, photocatalysts have been studied for their virucidal effects, such as those against SARS-CoV-2 [18], bovine coronavirus [19], influenza virus [20], tobacco mosaic viruses [21], phages [22], human adenovirus [8], human hepatitis B viruses [23], herpes simplex virus [13], as well as prions [24,25]. Viral inactivation using TiO2 was dependent on the UVA light intensity and exposure time [20]. Inactivation of the virus in suspension was as efficient as that on a TiO2-coated glass slide. Nakano et al. [20] also reported that viral proteins were primarily attacked during photocatalysis. After the destruction of the outer viral protein, the viral RNA was targeted.
This review primarily focuses on influenza viruses, SARS-CoV-2, and prions, owing to their involvement in major global pandemic incidents since 2000, including in the Japanese community. Recently, 222-nm UV rays have been shown to be effective against SARS-CoV-2; they do not exert any harmful effects on the skin eyes. This represents a major development in photocatalysis research. In this review, we briefly describe the prospects of using these UV rays for curtailing virus reproduction and transmission. Moreover, photocatalysts effectively reduce the infectivity of prions. Photocatalytic treatment is effective for destroying nucleic acids and proteins in vitro [26]. Photocatalytic treatment of liquid waste is a powerful tool for disinfection of the scrapie agent, and the described method could be adapted for use in surgical tool decontamination. Thus, we also discuss the application of photocatalysts for the treatment of diseases caused by prion-like amyloid or prionoids.

2. Decontamination of Influenza Viruses

The highly pathogenic avian influenza (HPAI) A (H5N1) virus, reported from avian species [27], is highly transmissible; and its infection is potentially fatal, particularly in domestic poultry. An Asian origin HPAI H5N1 virus has been responsible for high mortality in poultry and wild birds in Asia, the Middle East, Europe, and Africa since December 2000. To our knowledge, no H5 virus infections have been reported in humans in the United States or Japan to date [27]. HPAI viruses isolated from infected poultry cannot adapt to survive in human hosts [27]. However, sporadic infections due to other similar H5 viruses (e.g., H5N1 and H5N6) have been reported to afflict the human respiratory system and have high fatality rates [27]. Such infections have been reported in countries where personnel do not use appropriate personal protective equipment (PPE). PPE use is beneficial during direct physical contact with infected birds or virus-contaminated surfaces, i.e., when in the vicinity (within approximately 6 feet) of infected birds or visiting a live poultry market. Avian influenza infection in humans is unlikely when appropriately cooked poultry is consumed. However, direct or close (within 6 feet) contact with infected poultry or virus-contaminated equipment without using PPE may aggravate the risk of human infection [27]. Therefore, decontamination of infected birds or virus-contaminated surfaces is critical to public health.
Nakano et al. [20] expanded the photocatalysis effect of TiO2 to the field of virology. In their study, they used A/PR8/H1N1 influenza virus and demonstrated photocatalytic inactivation of a viral suspension prepared in Dulbecco’s modified eagle medium using TiO2. The viral titer decreased by approximately 4 log10 in 8 h. Photocatalysis primarily destroys the ligand protein on the envelope, which could be involved in receptor binding on the cell surface [20] (Table 1 and Table 2).
In 2009, a novel human influenza virus that originated from a swine influenza virus H1N1 (SIV) emerged in Mexico, and the infection was declared a pandemic by the World Health Organization on 11 June [28]. Precautionary regular hand washing was recommended because the primary routes for human transmission included aerosol and droplet infection. Abiotic surfaces, such as tables and walls, are additional sources of viral transmission through indirect contact. Virucidal treatment of these sources can reduce the virus transmission risk. Takehara et al. [28] used a platinum-loaded tungsten trioxide (Pt-WO3)-based photocatalyst—ILUMIO (Sumitomo Chemical Co. Ltd., Tokyo, Japan) [28] to reduce the risk of viral transmission through abiotic surfaces. This Pt-WO3-based photocatalyst was capable of absorbing visible light up to a wavelength of 470 nm and could efficiently break down organic material [28]; the avian isolated virus A/northern pintail/Miyagi/1472/18 (H1N1) was used in this study. The virus was exposed to a fluorescent lamp of 103 lux without UV light for up to 120 min. The recovered virus was transferred to microtubes and cultured in Madin-Darby bovine kidney cells. The residual viral load was below the detection limit i.e., >5.3 log inactivation within a 120-min exposure time [28] (Table 1 and Table 2).

3. Decontamination of SARS-CoV-2

3.1. Decontamination of SARS-CoV-2 by Photocatalysts

The COVID-19 pandemic has brought into focus the identity and role of “reservoir hosts” (such as bats) [31], “novel hosts” (such as humans), and “intermediate hosts” (such as pangolins [32,33] and raccoon dogs), which act as a connecting link between the reservoir and novel host. Healthcare professionals prefer placing humans at the end of the chain of the COVID-19 advent; however, such a human-centric approach is sometimes insufficient to understand the true scenario. Preventive strategies against zoonotic diseases are limited. More rigorous and effective monitoring at the animal-human interface is presumably the easiest way to mitigate future pandemics [33]. However, wildlife harbors a large, diverse, and continuously evolving virus pool. Moreover, determining the infectivity of these viruses in human cells is time-consuming and costly. Similar to the application of social distancing to control COVID-19 transmission, efficient segregation of humans from wildlife and their associated viruses should be practiced to minimize viral mobility and host mortality. It is critical to establish some form of global “pandemic radar”, which indicates sporadic zoonotic events with the potential for a full-blown disease outbreak. These systems should have ease of accessibility [34] and involve regular immunological surveillance to identify specific groups of viruses [35], such as coronaviruses.
Indoor disinfection strategies are important in controlling COVID-19 transmission, particularly in hospitals and zoos [36]. Reagents for indoor use with the highest virucidal activity against SARS-CoV-2 include mechanical ventilation [37], ethanol, sodium hypochlorite, and electrolyzed water [38]. Uema et al. used a tungsten trioxide (WO3) visible light-responsive photocatalyst named RENECAT (Toshiba Materials, Kanagawa, Japan) against SARS-CoV-2 for a 6-h fluorescent light exposure at 20 °C (FL20SSW/18, Toshiba Lighting & Technology, Kanagawa, Japan) [29] and reported successful inactivation of SARS-CoV-2 on a glass slide surface coated with WO3 (Table 1 and Table 2).
Graphene derivatives have shown potential virucidal effects against SARS-CoV-2 [18]. To disinfect water using visible light, graphene oxide (GO) layers were integrated with WO3 films (graphene-WO3); this decreased the MS2 phage titer from 2 × 106 plaque-forming units (PFU)/mL to <5 PFU/mL [39]. In this method, light illumination below 400 nm was used for 180 min. Recently, the virucidal effects of graphene derivatives against SARS-CoV-2 have also been reported [40]. Graphene platforms with long alkyl groups (C11) have been used to understand the inhibitory effects of graphene against SARS-CoV-2. Strong inhibition of SARS-CoV-2 has been observed using graphene with polyglycerol sulfate coverage (G-PGS)-C11 using the plaque reduction assay of SARS-CoV-2 [18,40]. A review by Patial et al. indicated the role of nanomaterials, such as graphene, in inactivating SARS-CoV-2 and that it displayed dose-dependent inhibition efficacy [18]. However, this is preliminary research, and further studies are necessary.
Although the virucidal effects of TiO2/UV as photocatalysts have been reported, the virucidal mechanisms of ROS remain unclear [41]. According to Liga et al. [42,43], non-enveloped viruses are more sensitive to the oxidizing effect of hydroxyl radicals than enveloped viruses. However, there is a lack of consensus on these observations. Nakano et al. [44] reported that non-enveloped viruses exhibit greater resistance to TiO2/UV toxicity than enveloped viruses. They examined the susceptibility of feline calicivirus (FCV, non-enveloped virus) and influenza virus (IFV, enveloped virus) to the TiO2/UV process. Compared to that of IFV, the titer of FCV required twice the time to decrease to a level below the detection limit. They concluded that the phospholipid membrane of the viral envelope transmits damage signals to the capsid protein much more rapidly than those in non-capsid viruses, such as FCV [44].
Recently, Matsuura et al. reported the inactivation of SARS-CoV-2 using the TiO2/LED system on TiO2-coated glass slides and aerosols in a photocatalytic chamber [17]. Photocatalytic chambers are used as electric air-cleaners, which operate using a 405-nm UV light for 20 min. This system induces ROS formation in the chamber, efficiently destroying virus S proteins, envelope proteins, and viral RNA. The SARS-CoV-2 suspension (1 mL; titer, 1.0 × 105 Median Tissue Culture Infectious Dose [TCID50]/mL) was placed on a TiO2-coated sheet; in the TiO2 + light group, SARS-CoV-2 was exposed to light-emitting diodes for 120 min, and the viral titer was subsequently confirmed using the TCID50 assay; the values were below the detection limit (<1.0 TCID50/mL). However, the effectiveness of the photocatalyst must be evaluated in practical applications. Furthermore, the duration for which the photocatalyst retains its virucidal activity against SARS-CoV-2 needs to be determined through continuous viral exposure testing (Table 1 and Table 2).
Additionally, Yoshizawa et al. reported that visible-light responsive photocatalyst, composed of 70% peroxo-titanium acid and 30% peroxo-modified anatase (Wako Filter Technology, Ibaraki, Japan), was effective in inactivating bovine coronaviruses (Figure 1 and Figure 2) [19]. Six test films (three each of photocatalytically coated and uncoated films) were placed in Petri dishes. The viral suspensions were maintained on the films with or without fluorescent light during the test at 25 ± 3 °C at 1000 lux light exposure for 4 h. The photocatalyst reduced the viral load by 2.8 log10 TCID50/0.1 mL [19] (Table 1 and Table 2).
TiO2 is a useful material for photocatalytic degradation of pollutants in water [45]. Currently, TiO2 is mainly immobilized in the form of films as self-cleaning coatings to avoid the loss of nanoparticles into water and allow long-term pollutant degradation. Moreover, hybridization with other materials can improve the physicochemical properties of the film. Particularly, silicon resin is a popular component used for nanoparticle-polymer complex coatings [46]. Double ligand phase spray deposition is widely used for TiO2-silicon resin composition films [47] as it demonstrates excellent durability and photocatalytic activity under long-term hydrodynamic erosion. Excessive curing leads to the complete hardening of silicon resin and precludes the firm bonding of TiO2 particles, resulting in excessive particle shedding and a decrease in photocatalytic efficiency [45,47]. Conditioning for an appropriately curved resin layer could efficiently fix the TiO2 particles on the film on a glass substrate. This will allow the high photocatalytic efficiency to be preserved after long-term hydrodynamic scouring [45]. More studies are necessary to determine the ideal fabrication methods.

3.2. Decontamination of SARS-CoV-2 by 222-nm UV Light

222-nm UV light was recently reported to disinfect SARS-CoV-2-contaminated surfaces [48]. A low dose of 222-nm UV light exhibited very weak penetration of the skin and eyes [49]. The most common UV system for anti-microbe lamps involves 254-nm UV radiation C (UVC). Unfortunately, 254-nm UVC is harmful to the skin and eyes [50]. Far-UVC light (207–222 nm) exhibits an efficient germicidal effect and is less harmful to the skin and eyes [51]. Previous studies have reported that 222-nm UV light is effective in mitigating methicillin-resistant Staphylococcus aureus (MRSA) contamination in hospital-use-only mobile phones [50]. Therefore, further studies should elucidate the use of 222-nm UV light to reduce the amount of SARS-CoV-2 in hospital aerosols.

4. Decontamination of Scrapie Prions

Prions are the causative agents of fatal neurodegenerative diseases such as transmissible spongiform encephalopathies (TSEs), including Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy in cattle, and scrapie in sheep and goats [52,53,54]. The only known component of a prion is the modified form of the cellular glycoprotein PrPC, encoded by the PRNP gene [55], termed PrPSc. The central event in prion pathogenesis is the conformational conversion of PrPC into PrPSc [52]. Extreme autoclaving conditions (134 °C, 18 min) are required to inactivate prions. Indeed, some prions retain transmissibility after dry-heating at 400 °C [56]. Prions are inactivated upon treatment with sodium dodecyl sulfate, sodium hydroxide, and sodium hypochlorite [56]; however, the use of these chemicals is impractical because of their corrosive properties. Paspaltsis et al. demonstrated that TiO2-mediated photocatalytic oxidation significantly reduces the infectivity of scrapie prions [24], and Berberidou et al. reported the potential of homogenous photocatalysis using photo-Fenton reagent driven by UVA irradiation [25,57].
ROS induced during TiO2/UVA application inactivate prions [24]. Paspaltsis et al. confirmed non-specific protein oxidation mediated by TiO2 in the presence of UVA [24]. After treatment with TiO2/H2O2, complete degradation of the brain protein (including prions) was observed. PrPC decomposition was observed after 30 min of TiO2/UV treatment in the presence of 0.8% colloidal nano-TiO2. PrPSc disappeared after 60 min of treatment in the TiO2/UV system. PrPSc was more resistant to ROS than PrPC [24]. This phenomenon was attributed to the difference in protein secondary structure between PrPC and PrPSc [58]. Thus, it was assumed that a different secondary structure implies a different physicochemical structure. However, many scientists believe that the secondary structure of PrPSc is hypothetical [52]. Furthermore, it is impossible to study the PrPSc secondary structure using nuclear magnetic resonance (NMR) because of the hydrophobic nature of PrPSc. PrPSc was not detectable in Western blots after treatment with TiO2, UVA, and H2O2. Another study showed that TiO2 catalytic treatment is effective for destroying nucleic acids and proteins in vitro [26]. The photocatalytic treatment of liquid waste is a powerful tool for disinfection of the scrapie agent, and the described method could be adapted for the decontamination of surgical tools.

5. Future Prospects for Decontamination of Prionoids

5.1. Transmission of Amyloid A Amyloidosis and Bovine Aβ

Prionoid transmission causes various diseases in humans and animals [59]. Several protein aggregates linked to these disorders have been observed to undergo cycles of nucleation and fragmentation, as occurs in prions [59]. A study in co-isogenic Prnp-deficient mice for a thorough reassessment of the functions previously attributed to PrPC revealed novel functions of PrPC [34]. Contamination of surgical tools is the main route of transmission of prions [59]. Thus, TiO2/UV-based disinfection of medical tools is necessary in human and veterinary medicine to reduce TSE transmission in the iatrogenic pathway.
Several prionoid-mediated disorders are characterized by systemic aggregate deposition in dialysis-related amyloidosis amyloid A in reactive amyloidosis [60]. This disease is mainly observed in the kidney glomeruli and includes aggregation of immunoglobulin light-chain amyloidosis, transthyretin in familial amyloid polyneuropathy, and β2-microglobulin. As a precursor protein, serum amyloid A (AA) is involved in the refractory systemic AA amyloidosis. This disease has also been reported in several domestic animals and birds. Murakami et al. observed AA amyloidosis transmission primarily in bovine and avian samples [60]. Nuclear formation and fibril extension were observed as the two steps of amyloid formation (Figure 3). Although there is species-specificity in AA transmission, interspecies transmissions are also observed occasionally. After AA is received from different species as a nucleus, the AA amyloid concentration increases via de-novo proliferation. This proliferation involves host proteins and carbohydrates for pathogenesis. Inoculated AA or their precursors never proliferate in this system. AA proliferates de novo without using DNA or RNA systems [61]. Additionally, for transmission, large amounts of precursor AA proteins are needed. In this aspect, the de novo mechanism is different from prion replication. TSEs need a longer incubation period than AA, even under the increased levels of cellular prion protein content [61]; longer incubation periods are not necessary for bovine and avian amyloidosis.
In-vitro studies on AA have shown that an equilibrium state is reached between the precursor protein and amyloid. Larger amounts of precursors are necessary to form amyloids. When the amount of precursor protein decreases, amyloid is refolded into precursor protein [62]. The quantity of amyloid fibrils can also be decreased by macrophage phagocytosis. In human patients with AA amyloidosis, when the SAA level is suppressed with medication, the amount of amyloid deposits in organs declines after a long period [63]. Since the TiO2/UVA system decreases prion quantities, it may be useful in decreasing serum AA levels in these patients. There is a species-specificity similar to that observed for PrPSc during cross-species transmission of AA amyloidosis.
Recently, many studies showed amyloid deposition in foods, such as beef and foie gras [64,65]. The amyloid enhancing factor (AEF) effect was seen in mice that were given per os with bovine AA (bAA) fibril [66]. There are concerns about human safety regarding AA amyloid transmission via amyloid-contaminated food [67]. However, it is unknown whether the transmission efficiency between different species is lower than that between the same species [68,69]. Iwaide et al. studied the oral transmission of bAA in 6-week-old mice and showed that fibrils consisting of bAA were derived from cows affected with hepatic AA amyloidosis [69]. None of the mice that were administered bAA developed amyloidosis; however, Peyer’s patches were observed based on immunohistochemistry analysis. Notably, 1 day after the injection, only one out of three mice showed bAA in the mesenteric lymph nodes. The authors concluded that AA amyloid did not show bovine-mouse interspecies transmission [69]. Moreover, they did not detect amyloidosis and hypothesized that blood bAA level was not sufficiently high to induce AEF activity because oral adsorption of bAA was not sufficient. Oral adsorption of bAA may be more efficient in younger or suckling mice. However, more studies are required to validate this hypothesis [69].
Ano et al. studied the oral transmission of bovine amyloid β (Aβ) in 2-week-old suckling cows (n = 3) and a 6-month-old cow (n = 1) [70]. Bovine Aβ and enhanced green fluorescent protein (Aβ-EGFP) solution (10 mg/mL) were administered to the cows (300 mL); this process was repeated 12 and 15 h after the first administration. The animals were euthanized 3 h after the last administration. Aβ-EGFP was detected in the villous epithelium in the ileum of the 2-week-old cows. Based on the fluorescence detected via Aβ- EGFP, the authors determined that Aβ was distributed only in the cytoplasm of the intestinal epithelial cells (Figure 4). Immunocytochemistry using the anti-EGFP antibody confirmed these results [70]. This distribution was also observed with Aβ-EGFP administration in a 6-month-old cow; however, the distribution in the intestinal epithelial cells was less frequent than that in 2-week-old cows (Figure 5). Aβ-EGFP uptake through the intestinal epithelium could be a superior model for studying Aβ incorporation in food and animals. Further studies on AA and Aβ transmissions are necessary.

5.2. Induction of Aβ Deposition, Islet Amyloid Polypeptide Deposition, and Cerebral Aβ-Amyloid Angiopathy

Misfolded aggregates of islet amyloid polypeptides (IAPPs, amylin) are commonly observed in type 1 and 2 diabetes. IAPPs are reported as extracellular depositions from pancreatic islets [71]. IAPPs are produced in β-cells and secreted with insulin and move with blood circulation. They are misfolded in β-cells and develop the tendency to aggregate and mediate toxic oligomers [71]. An in-vitro study showed that the Islet IAPPs were misfolded and deposited in β-cells. This result indicated that IAPPs are prionoids [72]. IAPP deposition in pancreatic β-cells increases with the development of type 1 and 2 diabetes mellitus. Clinical manifestation involves hyperglycemia, impaired glucose tolerance, and a decrease in the number of pancreatic β-cells. Type 1 diabetes is accompanied by insulitis. IAPP accumulation plays an important role in the manifestation of type 1 and 2 diabetes, and reducing IAPP levels in blood circulation using photocatalysis can interfere with diabetes progression.
Iatrogenic induction of Aβ deposition is suspected in patients exposed to cadaveric pituitary-derived hormones, dura grafts, or surgical tools contaminated by Aβ [73]. Administration of human Alzheimer’s disease (AD) brain homogenates containing Aβ aggregates to transgenic mice expressing human amyloid precursor protein induced cerebral β-amyloidosis and its pathology. However, Aβ-immunodepleted homogenates failed to induce lesions in mice. This suggests that amyloidosis induction is Aβ-dependent. Experiments on mice demonstrated that Aβ alone is sufficient for self-propagation in vitro, as in vitro-generated Aβ aggregates can induce amyloidosis [74]. Iatrogenic CJD (iCJD) has been demonstrated with dura matter grafting and is associated with Aβ accumulation in brain tissue [75]. This makes Aβ a strong candidate for prionoids [75]. A study revealed that patients with cadaver-derived human growth hormone (hGH)-related iCJD display tau-pathology that was linked to tau contaminations in respective hGH samples [76]. Confirmation of tau aggregates must be done using drug samples with or without tau. Thereafter, cadaveric hGH can be considered the possible source of tau transmissibility. Thus, further studies are required for validation.
Recently, eight human cases with iCJD, acquired via cadaver-derived hGH injection, were reported to have Aβ disease and pathology [77]. However, whether the hGH samples were the source of Aβ aggregation should be confirmed. Moreover, some patients showed tau-pathology; therefore, it must be clarified whether cadaveric hGH samples can induce tau-pathology. These patients may represent the first cases of iatrogenic Aβ transmission. Since then, there have been several reports of Aβ deposition following neurosurgical procedures involving dura matter grafting, as well as after cadaveric hGH inoculation in younger patients, from all over the world including Japan [78]. Although these authors did not suggest that AD is contagious [77], epidemiological studies have shown that it is transmissible [79,80]. Another report shows that it is important to evaluate the risk of iatrogenic transmission of cerebral Aβ-amyloid angiopathy (CAA) and potentially AD [81]. Currently, efficient disease-modifying drugs for AD are not available [81]. It is important to develop a method for disinfection against prionoid seeds from surgical tools. Application and development of photocatalysis-based methods should also be considered.

5.3. Aggregates of α-Synuclein

Aggregates of α-synuclein have been linked to neurodegenerative diseases, particularly Parkinson’s disease (PD) [82]. Similarly, the brain homogenates of patients with multiple systemic atrophy (MSA) induced α-synuclein phosphorylation and aggregation in mice [82]. A typical characteristic of prions is maintaining infectivity after serial passages. Since α-synuclein showed transmissibility after passages, α-synuclein could be a prionoid. In a mouse model, aggregation of α-synuclein induced by the brain homogenates required the presence of a hemizygous human mutant α-synuclein gene [83]. PD mouse models exhibit a neurological disorder similar to human PD. These complicated results indicate that the α-synuclein aggregates are heterogenous in different diseases. They differ from original diseases not only in cell type (neuronal inclusion bodies in dementia with Lewy bodies and PD; glial inclusion in MSA) but also in their potential for further propagation in mice [83,84].
A 2016 study showed that spinal cord homogenates prepared from wild-type and α-synuclein-null mice could induce α-synuclein deposits in mice hemizygous for the mutated human α-synuclein transgene [85]. When the mutated human α-synuclein gene is present in mice, they develop α-synuclein pathology after intracerebral injection of α-synuclein-null mouse spinal cord homogenate [52]. Some unknown factor in the spinal cord was inducing PD in the central nervous systems. Another study on patients with PD [86] who were transplanted with human embryonic neurons reported that although the original neurons were young at the time of transplantation, the grafts developed α-synuclein inclusions 10–24 years later. This shows that α-synuclein aggregates could spread from host to graft in a prion-like manner [87,88], which is a matter of concern in the field of neuroscience.
Currently, some proteins may be classified as prionoids, especially the aggregated forms of synuclein and amyloid A. Moreover, if they are shown to be infectious, they may be reclassified as true prions [59]. However, it is important to devise strategies for the disinfection of proteopathic seeds from surgical instruments as a precautionary measure. Previous studies on prion diseases have focused on protein misfolding disorders. Future studies on prions are likely to focus on understanding aggregation-induced toxicity.

6. Conclusions

Nakano et al. expanded the use of the photocatalysis exhibited by TiO2 to the field of virology, showing its virucidal effects against the influenza virus [20]. However, many unknown factors are involved in the mechanisms behind the virucidal effect of TiO2, except for ROS as their role has been elucidated. Because of the COVID-19 pandemic, several anti-viral compounds are being developed against SARS-CoV-2 using photocatalysts. The application of photocatalysis-based anti-viral compounds in indoor environments and public spaces is expected to decrease the viral load in aerosols. During the investigation of aerosols, 222-nm UV light was found to be effective against SARS-CoV-2 and did not exert any adverse effects on skin and eyes at least in mice and rats. Further evaluation of safety is needed to reduce the contamination of hospital or public buildings [48,49,89,90]. There are no conclusive studies on the use of 222-nm UV against prions. Since protein glycosylation in prions is sensitive to redox change [91], this redox system can control PrPC conversion to PrPSc. Thus, more studies are necessary to validate this mechanism. Moreover, as photocatalysis suppresses prion replication, effective conditions for surgical tools and dialysis machines are being explored to exclude the substances during the treatments.
Photocatalysts could be useful for the disinfection of abiotic materials indoors, such as walls, tables, and surfaces, using normal fluorescent light. For aerosol infections, photocatalyst filters could be useful to reduce the viral load in the air. Recently, a mesoscopic calcium bicarbonate solution (CAC-717) has been used to eliminate a variety of pathogens such as prions, influenza virus, SARS-CoV-2, and noroviruses [92,93,94,95,96] from fluids. CAC-717 can also act on the surfaces of human or animal bodies. A combination of the two methods could reduce the number of pathogens in the environment. Surface pH can be critical in promoting virucidal effects. SARS-CoV-2 is rapidly inactivated within 15 min at pH > 12 [94,96]. The inhibitory characteristics of cementitious materials also promote the photocatalytic activity of compounds that can inactivate microorganisms [97]. Furthermore, a gas plasma methodology is useful in disinfecting a variety of organisms [98,99]. Recently, there are increasing numbers of reports concerning prionoids in relation to such diseases as AD, PD, amyotrophic lateral sclerosis, and factors in metabolic diseases and cancer [59]. Since photocatalysts and CAC-717 are potent disinfectants for prions, disinfectants for prionoids may be developed by combining photocatalysis and CAC-717 treatment.

Author Contributions

T.O., M.H. and A.S. conceptualized the study. T.O. wrote the original draft. T.O., K.S., M.H., T.S., M.I., Y.I., Y.A., H.N. and A.S. wrote, reviewed, and edited the final draft of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

Orix and Santa Mineral provided financial support for the preparation of this article.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Wang, W.; Huang, G.; Yu, J.C.; Wong, P.K. Advance in photocatalytic disinfection of bacteria: Development of photocatalysts and mechanisms. J. Environ. Sci. 2015, 34, 232–247. [Google Scholar] [CrossRef] [PubMed]
  2. Foster, H.A.; Ditta, I.B.; Varghese, S.; Steele, A. Photocatalytic disinfection using titanium dioxide: Spectrum and mechanism of antimicrobial activity. Appl. Microbiol. Biotechnol. 2011, 90, 1847–1868. [Google Scholar] [CrossRef] [PubMed]
  3. Tseng, Y.H.; Sun, D.S.; Wu, W.S.; Chan, H.; Syue, M.S.; Ho, H.C.; Chang, H.H. Antibacterial performance of nanoscaled visible-light responsive platinum-containing titania photocatalyst in vitro and in vivo. Biochim. Biophys. Acta 2013, 1830, 3787–3795. [Google Scholar] [CrossRef] [PubMed]
  4. Xia, D.; Shen, Z.; Huang, G.; Wang, W.; Yu, J.C.; Wong, P.K. Red phosphorus: An earth-abundant elemental photocatalyst for “green” bacterial inactivation under visible light. Environ. Sci. Technol. 2015, 49, 6264–6273. [Google Scholar] [CrossRef] [PubMed]
  5. Leyland, N.S.; Podporska-Carroll, J.; Browne, J.; Hinder, S.J.; Quilty, B.; Pillai, S.C. Highly efficient F, Cu doped TiO2 anti-bacterial visible light active photocatalytic coatings to combat hospital-acquired infections. Sci. Rep. 2016, 6, 24770. [Google Scholar] [CrossRef]
  6. Wajima, T.; Nakaminami, H.; Aoki, S.; Seyama, S.; Noguchi, N. Evaluation of the antimicrobial effects of a novel visible light-driven photocatalyst in vitro and in the environment. Yakugaku Zasshi 2021, 141, 135–142. [Google Scholar] [CrossRef]
  7. Habibi-Yangjeh, H.A.; Asadzadeh-Khaneghah, S.; Feizpoor, S.; Rouhi, A. Review on heterogenous photocatalytic disinfection of waterborne, airborne, and foodborne viruses: Can we win against pathogenic viruses? J. Colloid Interface Sci. 2020, 580, 503–514. [Google Scholar] [CrossRef]
  8. Zhang, C.; Zhang, M.; Li, Y.; Shuai, D. Visible-light-driven photocatalytic disinfection of human adenovirus by a novel heterostructure of oxygen-doped graphitic carbon nitride and hydrothermal carbonation carbon. Appl. Catal. B Environ. 2019, 248, 11–21. [Google Scholar] [CrossRef]
  9. Hiragond, C.B.; Kshirsagar, A.S.; Dhapte, V.V.; Khanna, T.; Joshi, P.; More, P.V. Enhanced anti-microbial response of commercial face mask using colloidal silver nanoparticles. Vacuum 2018, 156, 475–482. [Google Scholar] [CrossRef]
  10. Sharma, V.K.; Yngard, R.A.; Lin, Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009, 145, 83–96. [Google Scholar] [CrossRef]
  11. Ren, G.; Hu, D.; Cheng, E.W.C.; Vargas-Reus, M.A.; Reip, P.; Allaker, R.P. Characterisation of copper oxide nanoparticles for antimicrobial applications. Int. J. Antimicrob. Agents 2009, 33, 587–590. [Google Scholar] [CrossRef] [PubMed]
  12. Ramyadevi, J.; Jeyasubramanian, K.; Marikani, A.; Rajakumar, G.; Rahuman, A.A. Synthesis and antimicrobial activity of copper nanoparticles. Mater. Lett. 2012, 71, 114–116. [Google Scholar] [CrossRef]
  13. Mishra, Y.K.; Adelung, R.; Röhl, C.; Shukla, D.; Spors, F.; Tiwari, V. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1. Antiviral Res. 2011, 92, 305–312. [Google Scholar] [CrossRef] [PubMed]
  14. Martinez-Gutierrez, F.; Olive, P.L.; Banuelos, A.; Orrantia, E.; Nino, N.; Sanchez, E.M.; Ruiz, F.; Bach, H.; Av-Gay, Y. Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticles. Nanomedicine 2010, 6, 681–688. [Google Scholar] [CrossRef]
  15. Perni, S.; Piccirillo, C.; Pratten, J.; Prokopovich, P.; Chrzanowski, W.; Parkin, I.P.; Wilson, M. The antimicrobial properties of light-activated polymers containing methylene blue and gold nanoparticles. Biomaterials 2009, 30, 89–93. [Google Scholar] [CrossRef]
  16. Mallakpour, S.; Azadi, E.; Hussain, C.M. The latest strategies in the fight against the COVID-19 pandemic: The role of metal and metal oxide nanoparticles. New J. Chem. 2021, 45, 6167–6179. [Google Scholar] [CrossRef]
  17. Matsuura, R.; Lo, C.W.; Wada, S.; Somei, J.; Ochiai, H.; Murakami, T.; Saito, N.; Ogawa, T.; Shinjo, A.; Benno, Y.; et al. SARS-CoV-2 disinfection of air and surface contamination by TiO2 photocatalyst-mediated damage to viral morphology, RNA, and protein. Viruses 2021, 13, 942. [Google Scholar] [CrossRef]
  18. Patial, S.; Kumar, A.; Raizada, P.; Van Le, Q.V.; Nguyen, V.H.; Selvasembian, R.; Singh, P.; Thakur, S.; Hussain, C.M. Potential of graphene based photocatalyst for antiviral activity with emphasis on COVID-19: A review. J. Environ. Chem. Eng. 2022, 10, 107527. [Google Scholar] [CrossRef]
  19. Yoshizawa, N.; Ishihara, R.; Omiya, D.; Ishitsuka, M.; Hirano, S.; Suzuki, T. Application of a photocatalyst as an inactivator of bovine coronavirus. Viruses 2020, 12, 1372. [Google Scholar] [CrossRef]
  20. Nakano, R.; Ishiguro, H.; Yao, Y.; Kajioka, J.; Fujishima, A.; Sunada, K.; Minoshima, M.; Hashimoto, K.; Kubota, Y. Photocatalytic Inactivation of influenza virus by titanium dioxide thin film. Photochem. Photobiol. Sci. 2012, 11, 1293–1298. [Google Scholar] [CrossRef]
  21. Yang, Y.; Yang, K.; Wang, J.; Cui, D.; Zhao, M. Fabrication and characterization of CdS nanowires templated in tobacco mosaic virus with improved photocatalytic ability. Appl. Microbiol. Biotechnol. 2021, 105, 8255–8264. [Google Scholar] [CrossRef] [PubMed]
  22. Cheng, R.; Kang, M.; Shen, Z.P.; Shi, L.; Zheng, X. Visible-light-driven photocatalytic inactivation of bacteriophage f2 by Cu-TiO2 nanofibers in the presence of humic acid. J. Environ. Sci. 2019, 77, 383–391. [Google Scholar] [CrossRef] [PubMed]
  23. Zan, L.; Fa, W.; Peng, T.; Gong, Z.K. Photocatalysis effect of nanometer TiO2 and TiO2-coated ceramic plate on hepatitis B virus. J. Photochem. Photobiol. B 2007, 86, 165–169. [Google Scholar] [CrossRef]
  24. Paspaltsis, I.; Kotta, K.; LagoudSakudo, A.; Lagoudaki, R.; Grigoriadis, N.; Poulios, I.; Sklaviadis, T. Titanium dioxide photocatalytic inactivation of prions. J. Gen. Virol. 2006, 87, 3125–3130. [Google Scholar] [CrossRef] [PubMed]
  25. Berberidou, C.; Xanthopoulos, K.; Paspaltsis, I.; Lourbopoulos, A.; Polyzoidou, E.; Sklaviadis, T.; Poulios, I. Homologous photocatalytic decontamination of prion infected stainless steel and titanium surfaces. Prion 2014, 7, 488–495. [Google Scholar] [CrossRef]
  26. Ashikaga, T.; Wada, W.; Kobayashi, H.; Mori, M.; Katsumura, Y.; Fukui, H.; Kato, S.; Yamanuichi, M.; Takamatsu, T. Effect of the photocatalytic activity of TiO2 on plasmid DNA. Mutat. Res. Genet. Toxicol. Environ. Mutag. 2000, 466, 1–7. [Google Scholar] [CrossRef]
  27. CDC. HPAI a H5 Virus Background and Clinical Illness. Available online: https://www.cdc.gov/flu/avianflu/hapi-background-clinical-illness.htm (accessed on 8 May 2022).
  28. Takehara, K.; Yamazaki, K.; Miyazaki, M.; Yamada, Y.; Ruenphet, S.; Jahangir, A.; Shoham, D.; Okamura, M.; Nakamura, M. Inactivation of avian influenza virus H1N1 by photocatalyst under visible light irradiation. Virus Res. 2010, 151, 102–103. [Google Scholar] [CrossRef]
  29. Uema, M.; Yonemitsu, K.; Momose, Y.; Ishii, Y.; Takeda, K.; Inoue, T.; Asakura, H. Effect of photocatalyst under visible light irradiation in SARS-CoV-2 stability on an abiotic surface. Biocontrol Sci. 2021, 26, 119–125. [Google Scholar] [CrossRef]
  30. Performance Standard (Photocatalysis Industry Association of Japan). Available online: https://www.piaj.gr.jp/roller/entry/20090121 (accessed on 20 October 2021).
  31. Holmes, E.C. COVID-19—Lessons for zoonotic disease. Science 2022, 375, 1114–1115. [Google Scholar] [CrossRef]
  32. Lam, T.T.-Y.; Ja, N.; Zhang, Y.-W.; Shum, M.H.-H.; Jiang, J.-F.; Zhu, H.-C.; Tong, Y.-G.; Shi, Y.-X.; Ni, X.-B.; Liao, Y.-S.; et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature 2020, 583, 282–285. [Google Scholar] [CrossRef] [Green Version]
  33. Liu, P.; Chen, W.; Chen, J.-P. Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica). Viruses 2019, 11, 979. [Google Scholar] [CrossRef]
  34. Carbis Bay G7 Summit Communique. Our Shared Agenda for Global Action to Build Back Better. Available online: https://www.g7/uk.org/wp-content/uploads/2021/06/Carbis-Bay-G7-Summit-Comunique-PDP-430KB-25-pages-3.pdf82021 (accessed on 20 July 2022).
  35. Xu, G.J.; Kula, T.; Xu, Q.; Li, M.Z.; Vernon, S.D.; Ndung’u, T.; Ruxrungtham, K.; Sanchez, J.; Brander, C.; Chung, R.T.; et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science 2015, 348, aaa0698. [Google Scholar] [CrossRef] [PubMed]
  36. Ahn, J.Y.; An, S.; Sohn, Y.; Cho, Y.; Hyun, J.H.; Baek, Y.J.; Kim, M.H.; Jeong, S.J.; Kim, J.H.; Ku, N.S.; et al. Environmental contamination in the isolation of COVID-19 patients with severe pneumonia requiring mechanical ventilation of high-flow oxygen therapy. J. Hosp. Infect. 2020, 106, 570–576. [Google Scholar] [CrossRef]
  37. Hu, T.; Ji, Y.; Fei, F.; Zhu, M.; Jin, T.; Xue, P.; Zhang, N. Optimization of COVID-19 prevention and control with low building energy consumption. Build. Environ. 2022, 219, 109233. [Google Scholar] [CrossRef] [PubMed]
  38. Leslie, R.A.; Zhou, S.S.; Macinga, D.R. Inactivation of SARS-CoV-2 by commercially available alcohol-based hand sanitizers. Am. J. Infect. Control 2021, 49, 401–402. [Google Scholar] [CrossRef]
  39. Akhavan, O.; Choobtashani, M.; Ghaderi, E. Protein degradation and RNA efflux of viruses photocatalyzed by graphene-tungstene oxide composite under visible light irradiation. J. Phys. Chem. C 2012, 116, 9653–9659. [Google Scholar] [CrossRef]
  40. Donskyi, I.S.; Nie, C.; Ludwig, K.; Trimpert, J.; Ahmed, R.; Quaas, E.; Achzi, K.; Radnik, J.; Adeli, M.; Haag, R. Graphene sheets with defined dual functionalies for the strong SARS-CoV-2 interactions. Small 2021, 17, 2007091. [Google Scholar] [CrossRef]
  41. Xu, R.; Liu, X.; Zhang, P.; Ma, H.; Liu, G.; Xia, Z. The photodestruction of virus in nano-TiO2 suspension. J. Wuhan Univ. Technol. 2007, 22, 422–425. [Google Scholar] [CrossRef]
  42. Liga, M.V.; Bryant, E.L.; Colvin, V.L.; Li, Q. Virus inactivation by silver doped titanium dioxide nanoparticles for drinking water treatment. Water Res. 2011, 45, 535–544. [Google Scholar] [CrossRef]
  43. Liga, M.V.; Maguire-Boyle, S.J.; Jafry, H.R.; Barron, A.R.; Li, Q. Silica decorated TiO2 for virus inactivation in drinking water-simple synthesis method and mechanisms of enhanced inactivation kinetics. Environ. Sci. Technol. 2013, 47, 6463–6470. [Google Scholar] [CrossRef]
  44. Nakano, R.; Hara, M.; Ishiguro, I.; Yao, Y.; Ochiai, I.; Nakata, K.; Murakami, T.; Kajioka, J.; Sunada, K.; Hashimoto, K.; et al. Broad spectrum microbial activity of photocatalysis by TiO2. Catalysis 2013, 3, 310–323. [Google Scholar] [CrossRef]
  45. Zhang, L.; Rao, L.; Wang, P.; Guo, X.; Wang, Y. Fabrication and photocatalytic performance evaluation of hydrodynamic erosion-resistant nano-TiO2-silicone resin composite films. Environ. Sci. Pollut. Res. 2019, 26, 4997–5007. [Google Scholar] [CrossRef] [PubMed]
  46. Zuo, W.; Feng, D.; Song, A.; Gong, H.; Zhu, S. Effects of organic-inorganic hybrid coating on the color stability of denture base resins. J. Prosthet. Dent. 2016, 115, 103–108. [Google Scholar] [CrossRef] [PubMed]
  47. Xiang, H.; Ge, J.; Cheng, S.; Han, H.; Cui, S. Synthesis and characterization of titania/mq silicon resin hybrid nanocomposite via sol-gel process. J. Sol-Gel Sci. Technol. 2011, 59, 635–639. [Google Scholar] [CrossRef]
  48. Kitagawa, H.; Nomura, T.; Nazmul, T.; Omori, K.; Shigemoto, N.; Sakaguchi, T.; Ohge, H. Effectiveness of 222-nm ultraviolet light on disinfecting SARS-CoV-2 surface contamination. Am. J. Infect. Control 2021, 49, 299–301. [Google Scholar] [CrossRef]
  49. Mariita, R.M.; Davis, J.H.; Randive, R.V. Illuminating human noroviruses: A perspective on disinfection of water and surfaces using uvc, norovirus model organisms, and radiation safety considerations. Pathogens 2022, 11, 226. [Google Scholar] [CrossRef]
  50. Kaiki, Y.; Kitagawa, H.; Hara, T.; Nomura, T.; Omori, K.; Shigemoto, N.; Takahashi, S.; Ohge, H. Methicillin-resistant Staphylococcus aureus Contamination of hospital-use-only mobile phones and efficacy of 222-nm ultraviolet disinfection. Am. J. Infect. Control 2021, 49, 800–803. [Google Scholar] [CrossRef]
  51. Yamano, N.; Kunisada, M.; Kaidzu, S.; Sugihara, K.; Nishiaki-Sawada, A.; Ohashi, H.; Yoshioka, A.; Igarashi, T.; Ohira, A.; Tanito, M.; et al. Long-term effects of 222-nm ultraviolet radiation C sterilizing lamps on mice susceptible to ultraviolet radiation. Photochem. Photobiol. 2020, 96, 853–862. [Google Scholar] [CrossRef]
  52. Aguzzi, A.; Calella, A.M. Prions: Protein aggregation and infectious diseases. Physiol. Rev. 2009, 89, 1105–1152. [Google Scholar] [CrossRef]
  53. Prusiner, S.B. Prions. Proc. Natl. Acad. Sci. USA 1998, 95, 13363–13383. [Google Scholar] [CrossRef] [Green Version]
  54. Sakudo, A.; Xue, G.; Kawashita, N.; Ano, Y.; Takagi, T.; Shintani, H.; Tanaka, Y.; Onodera, T.; Ikuta, K. Structure of the prion protein and its gene: An analysis using bioinformatics and computer simulation. Curr. Protein Pept. Sci. 2010, 11, 166–179. [Google Scholar] [CrossRef] [PubMed]
  55. Stahl, N.; Brochelt, D.R.; Hsiao, K.; Prusiner, S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987, 51, 229–240. [Google Scholar] [CrossRef]
  56. Matsuura, Y.; Ishikawa, Y.; Murayama, Y.; Yokoyama, T.; Somerville, R.A.; Kitamoto, T.; Mohri, S. Eliminating transmissibility of bovine spongiform encephalopathy by dry-heat treatment. J. Gen. Virol. 2020, 101, 136–142. [Google Scholar] [CrossRef] [PubMed]
  57. Paspaltis, I.; Berberidou, C.; Poulios, I.; Sklaviadis, T. Photocatalytic degradation of prions using the photo-fenton reagent. J. Hosp. Infect. 2009, 71, 149–156. [Google Scholar] [CrossRef]
  58. Bodgan, J.; Zarzynnka, J.; Plawrinska-Czarnak, J. Comparison of infectious agents susceptibility to photocatalytic effects of nanosized titanium and zinc oxides: A practical approach. Nanoscale Res. Lett. 2015, 10, 1–5. [Google Scholar] [CrossRef]
  59. Scheckel, C.; Aguzzi, A. Prions, prionoids and protein misfolding disorders. Nat. Rev. Genet. 2018, 19, 405–418. [Google Scholar] [CrossRef]
  60. Murakami, T.; Inoshima, Y.; Ishiguro, N. Systemic AA Amyloidosis as a prion-like disorder. Virus Res. 2015, 207, 76–81. [Google Scholar] [CrossRef]
  61. Soto, C.; Estrada, L.; Castilla, J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci. 2006, 31, 150–155. [Google Scholar] [CrossRef]
  62. Yamaguchi, K.; Kamatari, Y.O.; Fukuoka, M.; Miyaji, R.; Kuwata, K. Nearly reversible conformational change of amyloid fibrils as revealed by pH-jump experiments. Biochemistry 2013, 52, 6797–6806. [Google Scholar] [CrossRef]
  63. Miyagawa, I.; Nakayamada, S.; Saito, K.; Hanami, K.; Nawata, M.; Sawamukai, N.; Nakano, K.; Yamaoka, K.; Tanaka, Y. Study on the safety and efficacy of tocilizumab, an Anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis. Mod. Rheumatol. 2014, 24, 405–409. [Google Scholar] [CrossRef]
  64. Tojo, K.; Tokuda, T.; Hoshii, Y.; Fu, X.; Higuchi, K.; Matsui, T.; Kametani, F.; Ikeda, S. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in japan. Amyloid 2005, 12, 103–108. [Google Scholar] [CrossRef] [PubMed]
  65. Solomon, A.; Richey, T.; Murchy, C.L.; Weiss, D.T.; Wall, J.S.; Westermark, G.T.; Westermark, P. Amyloidogenic potential of foie gras. Proc. Natl. Acad. Sci. USA 2007, 104, 10998–11001. [Google Scholar] [CrossRef] [PubMed]
  66. Cui, D.; Kawano, H.; Hoshii, Y.; Liu, Y.; Ishihara, T. Acceleration of murine AA amyloid deposition by bovine amyloid fibril and tissue homogenates. Amyloid 2008, 15, 77–83. [Google Scholar] [CrossRef] [PubMed]
  67. Liu, Y.; Cui, D.; Hoshii, Y.; Kwano, H.; Une, Y.; Gondo, T.; Ishihara, T. Induction murine AA Amyloidosis by various homogenous amyloid fibrils and amyloid-like synthetic peptides. Scand. J. Immunol. 2007, 66, 495–500. [Google Scholar] [CrossRef] [PubMed]
  68. Ogawa, S.; Murakami, T.; Inoshima, Y.; Ishiguro, N. Effect of heating on the stability of amyloid a (AA) fibrils and the intra- and cross-species transmission of aa amyloidosis. Amyloid 2015, 22, 236–243. [Google Scholar] [CrossRef] [PubMed]
  69. Iwaide, S.; Ujike, N.; Kobayashi, K.; Sassa, Y.; Murakami, T. Species-barrier on the cross-species oral transmission of bovine aa amyloidosis in mice. J. Vet. Med. Sci. 2012, 83, 962–967. [Google Scholar] [CrossRef]
  70. Ano, Y.; Nakayama, H.; Sakai, Y.; Sakudo, A.; Endo, M.; Ebisu, S.; Li, J.-Y.; Uetsuka, K.; Manabe, N.; Onodera, T. Incorporation of β-amyloid protein through the bovine ileal epithelium before and after weaning: Model for orally transmitted amyloidosis. Microbiol. Immunol. 2008, 52, 429–434. [Google Scholar] [CrossRef]
  71. Beery, M.A.; Jacobsen, L.M.; Atkinson, M.A.; Butler, A.E.; Campbell-Thompson, M. Islet amyloidosis in a child with type 1 diabetes. Islet 2019, 11, 44–49. [Google Scholar] [CrossRef]
  72. Costes, S.; Langen, R.; Gurlo, T.; Matveyenko, A.V.; Butler, P.C. Beta-cell failure in type 2 diabetes: A case of asking too much of too few? Diabetes 2013, 62, 327–335. [Google Scholar] [CrossRef]
  73. Gary, C.; Lam, S.; Herard, A.-S.; Koch, J.E.; Petit, F.; Gipchtein, P.; Sawiak, S.J.; Caillrerez, R.; Eddarkaoui, S.; Colin, M.; et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathol. Commun. 2019, 7, 126. [Google Scholar] [CrossRef] [Green Version]
  74. Stohr, J.; Watts, J.C.; Mensinger, Z.L.; Oehler, A.; Grillo, S.K.; DeArmond, S.J.; Prusiner, S.B.; Giles, K. Purified and synthetic Alzheimer’s amyloid beta [Aβ] proteins. Proc. Natl. Acad. Sci. USA 2012, 109, 11025–11130. [Google Scholar] [CrossRef]
  75. Frontzek, K.; Lutz, M.I.; Aguzzi, A.; Kovacs, G.G.; Budka, H. Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting. Swiss Med. Wkly. 2016, 146, w14287. [Google Scholar] [CrossRef] [PubMed]
  76. Duyckaerts, C.; Sazdovitch, V.; Ando, K.; Seihean, D.; Privat, N.; Yilmaz, Z.; Peckeu, L.; Amar, E.; Comoy, E.; Maceski, A.; et al. Neuropathology of iatrogenic creutzfeldt-jakob disease and immunoassay of French Cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of aβ pathology. Acta Neuropathol. 2018, 135, 201–212. [Google Scholar] [CrossRef] [PubMed]
  77. Purro, S.A.; Farrow, M.A.; Linehan, J.; Nazari, T.; Thomas, D.X.; Chen, Z.; Mengel, D.; Saito, T.; Saido, T.; Rudge, P.; et al. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature 2018, 564, 415–419. [Google Scholar] [CrossRef] [PubMed]
  78. Hamaguchi, T.; Taniguchi, Y.; Sakai, K.; Kitamoto, T.; Takao, M.; Murayama, S.; Iwasaki, Y.; Yoshida, M.; Shimizu, H.; Kakita, A.; et al. Significant association cadaveric dura mater grafting with subpial aβ deposition and meningeal amyloid angiopathy. Acta Neuropathol. 2016, 132, 313–315. [Google Scholar] [CrossRef] [PubMed]
  79. Daviglus, M.L.; Plassman, B.; Pirzada, A.; Bell, C.C.; Bowen, P.E.; Burke, J.R.; Connolly, E.S.; Dunbar-Jakob, J.M.; Granieri, E.C.; McGarry, K.; et al. Risk factors and preventive interventions for Alzheimer disease: State of the science. Arch. Neurol. 2011, 68, 1185–1190. [Google Scholar] [CrossRef]
  80. O’Meara, E.S.; Kukull, W.A.; Schellenberg, G.D.; Bowen, J.D.; McCormick, W.C.; Teri, L.; Pfanschmidt, M.; Thompson, J.D.; Larson, E.B. Alzheimer’s disease and history of blood transfusion by apolipoprotein-e genotype. Neuroepidemiology 1997, 16, 86–93. [Google Scholar] [CrossRef]
  81. Jaunmuktane, Z.; Quaegebeur, A.; Taipa, R.; Viana-Baptista, M.; Barbosa, R.; Koriath, C.; Sciot, R.; Mead, S.; Brandner, S. Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery. Acta Neuropathol. 2018, 135, 671–679. [Google Scholar] [CrossRef]
  82. Watts, J.C.; Giles, K.; Oehler, A.; Middleton, L.; Dexter, D.T.; Gentleman, S.M.; DeArmond, S.J.; Prusiner, S.B. Transmission of multiple system atrophy prions to transgenic mice. Proc. Natl. Acad. Sci. USA 2013, 110, 1955–19560. [Google Scholar] [CrossRef]
  83. Prusiner, S.B.; Woeman, A.; Mordes, D.A.; Watts, J.C.; Rampersaud, R.; Berry, D.B.; Patel, S.; Oehler, A.; Lowe, J.K.; Kravitz, S.; et al. Evidence for α-synuclein prions causing multiple system atrophy in human with Parkinsonism. Proc. Natl. Acad. Sci. USA 2015, 112, E5308–E5317. [Google Scholar] [CrossRef] [Green Version]
  84. Sigurdson, C.J.; Nilsson, K.P.; Hornemann, S.; Manco, G.; Fernandez-Borges, N.; Schwarz, P.; Castilla, J.; Wuthrich, K.; Aguzzi, A. A molecular switch controls interspecies prion disease transmission in mice. J. Clin. Investig. 2010, 120, 2590–2599. [Google Scholar] [CrossRef]
  85. Sacino, A.N.; Ayers, J.; Brooks, M.M.; Chakrabarty, P.; Hudson, V.J., 3rd; Howard, J.K.; Golde, T.; Giasson, B.I.; Borchelt, D.R. Non-prion type transmission in a53t α-synuclein transgenic mice: A normal component of spinal homogenates from naïve non-transgenic mice induces robust α-synuclein pathology. Acta Neuropathol. 2016, 131, 151–154. [Google Scholar] [CrossRef] [PubMed]
  86. Kurowska, Z.; Englund, E.; Winder, H.; Lindvall, O.; Li, J.-Y.; Brundin, P. Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson’s disease. J. Parkinson’s Dis. 2011, 1, 83–92. [Google Scholar] [CrossRef] [PubMed]
  87. Kordower, J.H.; Chu, Y.; Hauser, R.A.; Freeman, T.B.; Olanow, C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson’s disease. Nat. Med. 2008, 14, 504–506. [Google Scholar] [CrossRef] [PubMed]
  88. Li, W.; Englund, E.; Widner, H.; Mattson, B.; van Westen, D.; Latt, J.; Rehncrona, S.; Brundin, P.; Bjorklund, A.; Lindvall, O.; et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating Parkinsonian brain. Proc. Natl. Acad. Sci. USA 2016, 113, 6544–6549. [Google Scholar] [CrossRef]
  89. Kahn, K.; Marita, R.M. Quantifying the Impact of Ultraviolet Subtype C in Reducing Airborne Pathogen Transmission and Improving Energy Efficiency in Healthy Buildings: A Kahn-Marita equivalent ventilation model. Front. Built Environ. 2021, 7, 1–10. [Google Scholar] [CrossRef]
  90. Cadet, J. Harmless effects of sterilizing 222-nm far-UV radiation on mouse skin and eye tissues. Photochem. Photobiol. 2020, 96, 949–950. [Google Scholar] [CrossRef]
  91. Capellari, S.; Zaidi, S.I.; Urig, C.B.; Perry, G.; Smith, M.A.; Petersen, R.B. Prion protein glycosylation is sensitive to redox change. J. Biol. Chem. 1999, 274, 34846–34850. [Google Scholar] [CrossRef]
  92. Nakashima, R.; Kawamoto, M.; Miyazaki, S.; Onishi, R.; Furusaki, K.; Osaki, M.; Kirisawa, R.; Sakudo, A.; Onodera, T. Evaluation of calcium hydrogen carbonate mesoscopic crystals as a disinfectant for influenza a viruses. J. Vet. Med. Sci. 2017, 79, 939–942. [Google Scholar] [CrossRef]
  93. Shimakura, H.; Gen-Nagata, F.; Haritani, M.; Furusaki, K.; Kato, Y.; Yamashita-Kawanishi, N.; Le, D.T.; Tsuzuki, M.; Tohya, Y.; Kyuwa, S.; et al. Inactivation of human norovirus and its surrogate by the disinfectant consisting of calcium hydrogen carbonate mesoscopic crystals. FEMS Microbiol. Lett. 2019, 366, fnz235. [Google Scholar] [CrossRef]
  94. Yokoyama, T.; Nishimura, T.; Uwamino, Y.; Kosaki, K.; Furusaki, K.; Onishi, R.; Onodera, T.; Haritani, M.; Sugiura, K.; Kirisawa, R.; et al. Virucidal effect of the mesoscopic structure of CAC-717 against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Microorganisms 2021, 9, 2096. [Google Scholar] [CrossRef] [PubMed]
  95. Kirisawa, R.; Kato, R.; Furusaki, K.; Onodera, T. Universal virucidal activity of calcium bicarbonate mesoscopic crystals that provides an effective and biosafe disinfectant. Microorganisms 2022, 10, 262. [Google Scholar] [CrossRef]
  96. Sakudo, A.; Iwamaru, Y.; Furusaki, K.; Haritani, M.; Onishi, R.; Imamura, M.; Yokoyama, T.; Yoshikawa, Y.; Onodera, T. Inactivation of scrapie prions by the electrically charged disinfectant CAC-717. Pathogens 2020, 9, 536. [Google Scholar] [CrossRef] [PubMed]
  97. Guerrini, G.L. Photocatalysis and virus. From theory to applications. J. Photocatal. 2021, 2, 25–34. [Google Scholar] [CrossRef]
  98. Sakudo, A.; Yagyu, Y.; Onodera, T. Disinfection and sterilization of microorganisms using gas plasma: Fundamentals and future perspectives for biological applications. Int. J. Mol. Sci. 2019, 20, 5216. [Google Scholar] [CrossRef]
  99. Sakudo, A.; Yamashiro, R.; Onodera, T. Recent advances in prion inactivation by plasma sterilizer. Int. J. Mol. Sci. 2022, 23, 10241. [Google Scholar] [CrossRef]
Applmicrobiol 02 00054 g001 550
Figure 1. Schematic of the equipment used for the assessment of antiviral activity of photocatalytic materials using visible light irradiation. The equipment was prepared in accordance with the ISO 18071 criteria prescribed by the International Organization for Standardization. (1) Light source (fluorescent lamp), (2) Petri dish (upper), (3) cover film, (4) virus suspension, (5) test piece, (6) glass rod, (7) paper filter, and (8) Petri dish (lower). Reproduced from [19], published under an open access Creative Commons CC BY 4.0 license. UV experiments were conducted following Radiation Safety, https://www.mdpi.com/2076-0817/11/2/226 (accessed on 10 April 2020).
Figure 1. Schematic of the equipment used for the assessment of antiviral activity of photocatalytic materials using visible light irradiation. The equipment was prepared in accordance with the ISO 18071 criteria prescribed by the International Organization for Standardization. (1) Light source (fluorescent lamp), (2) Petri dish (upper), (3) cover film, (4) virus suspension, (5) test piece, (6) glass rod, (7) paper filter, and (8) Petri dish (lower). Reproduced from [19], published under an open access Creative Commons CC BY 4.0 license. UV experiments were conducted following Radiation Safety, https://www.mdpi.com/2076-0817/11/2/226 (accessed on 10 April 2020).
Applmicrobiol 02 00054 g001
Applmicrobiol 02 00054 g002 550
Figure 2. Images of the immunofluorescence assay (IFA) using viral solutions from photocatalytic (a–c) uncoated and (d–h) coated films were collected every hour (with or without irradiation; 1000 lux light for 4 h). After inoculation with the collected viral solutions for 22 h, the cells were stained with anti-BCoV rabbit serum, followed by incubation with goat fluorescein-isothiocyanate conjugate anti-rabbit immunoglobulin (Ig)G, IgA, and IgM (green) and finally with 4′,6-diamidino-2-phenylindole) (blue). (a) Photocatalytically uncoated films after 0 h without treatment with 1000 lux visible light; (b) photocatalytically uncoated films after 4 h without treatment with visible light of 1000 lux; (c) photocatalytically uncoated films after 4 h with treatment with visible light of 1000 lux; (d) photocatalytically coated films after 4 h without treatment with visible light of 1000 lux; (e–h) photocatalytic coated films after (e) 1 h, (f) 2 h, (g) 3 h, and (h) 4 h of treatment with 1000 lux visible light. Scale bar = 100 μm. Reproduced from [19], published under an open access Creative Commons CC BY 4.0 license.
Figure 2. Images of the immunofluorescence assay (IFA) using viral solutions from photocatalytic (a–c) uncoated and (d–h) coated films were collected every hour (with or without irradiation; 1000 lux light for 4 h). After inoculation with the collected viral solutions for 22 h, the cells were stained with anti-BCoV rabbit serum, followed by incubation with goat fluorescein-isothiocyanate conjugate anti-rabbit immunoglobulin (Ig)G, IgA, and IgM (green) and finally with 4′,6-diamidino-2-phenylindole) (blue). (a) Photocatalytically uncoated films after 0 h without treatment with 1000 lux visible light; (b) photocatalytically uncoated films after 4 h without treatment with visible light of 1000 lux; (c) photocatalytically uncoated films after 4 h with treatment with visible light of 1000 lux; (d) photocatalytically coated films after 4 h without treatment with visible light of 1000 lux; (e–h) photocatalytic coated films after (e) 1 h, (f) 2 h, (g) 3 h, and (h) 4 h of treatment with 1000 lux visible light. Scale bar = 100 μm. Reproduced from [19], published under an open access Creative Commons CC BY 4.0 license.
Applmicrobiol 02 00054 g002
Applmicrobiol 02 00054 g003 550
Figure 3. Diagram of amyloid fibril formation and transmission of AA amyloidosis among animals. Misfolded proteins are generated by reconformation, and they form the nucleus, which acts as a seed. The seeds interact with serum AA protein (SAA) and extend fibrils through the seeding-nucleation process. Fragmentation of AA fibrils sometimes generates new seeds. The fibrils or fibril fragments in feces or tissues are ingested by animals belonging to homo or cross-species, leading to homo-species transmission or cross-species transmission, respectively. Cited from Murakami et al. [60] with permission from Elsevier.
Figure 3. Diagram of amyloid fibril formation and transmission of AA amyloidosis among animals. Misfolded proteins are generated by reconformation, and they form the nucleus, which acts as a seed. The seeds interact with serum AA protein (SAA) and extend fibrils through the seeding-nucleation process. Fragmentation of AA fibrils sometimes generates new seeds. The fibrils or fibril fragments in feces or tissues are ingested by animals belonging to homo or cross-species, leading to homo-species transmission or cross-species transmission, respectively. Cited from Murakami et al. [60] with permission from Elsevier.
Applmicrobiol 02 00054 g003
Applmicrobiol 02 00054 g004 550
Figure 4. Identification of bovine Aβ and enhanced green fluorescent protein (Aβ-EGFP)-incorporating cells. Aβ-EGFP-incorporating cells were both villin positive (yellow on the cell surface, white arrow) and negative (green on the cell surface, white arrowhead). Microvilli of the epithelial cells were positive for villin (red) [70]. Nuclei were stained with 4′,6′-diamidino-2-phenylindole dihydrochloride (DAPI). Scale bar = 25 μm. Modified from [70] with permission from Wiley.
Figure 4. Identification of bovine Aβ and enhanced green fluorescent protein (Aβ-EGFP)-incorporating cells. Aβ-EGFP-incorporating cells were both villin positive (yellow on the cell surface, white arrow) and negative (green on the cell surface, white arrowhead). Microvilli of the epithelial cells were positive for villin (red) [70]. Nuclei were stained with 4′,6′-diamidino-2-phenylindole dihydrochloride (DAPI). Scale bar = 25 μm. Modified from [70] with permission from Wiley.
Applmicrobiol 02 00054 g004
Applmicrobiol 02 00054 g005 550
Figure 5. Age-dependent Aβ EGFP uptake by the intestinal epithelium. The number of ileal epithelial cells incorporating Aβ-EGFP was significantly higher in 2-week-old cows than in a 6-month-old cow. Results are expressed as the mean + standard deviation. Statistical differences were determined by a Student t-test. ** p < 0.01 [70]. Modified from [70] with permission from Wiley.
Figure 5. Age-dependent Aβ EGFP uptake by the intestinal epithelium. The number of ileal epithelial cells incorporating Aβ-EGFP was significantly higher in 2-week-old cows than in a 6-month-old cow. Results are expressed as the mean + standard deviation. Statistical differences were determined by a Student t-test. ** p < 0.01 [70]. Modified from [70] with permission from Wiley.
Applmicrobiol 02 00054 g005
Table
Table 1. Antiviral effects of photocatalysts.
Table 1. Antiviral effects of photocatalysts.
PhotocatalystAgentPathogen LoadDuration of TreatmentsReference
Photocatalysis-UntreatedPhotocatalysis-Treated
Influenza
TiO2/Black Light (352 nm)H1N1>1.0 × 108.0 (TCID50/mL)undetectable8 h[20]
Pt-WO3H1N11.0 × 107.0 (TCID50/mL)<1.0 × 101.5 (TCID50/mL)6 h[28]
SARS-CoV-2
WO3JPN/TY/WK-5215.98 ± 0.38 log10 (TCID50/mL)3.05 ± 0.25 log10 (TCID50/mL)6 h[29]
TiO2/LEDJPN/TY/WK-5211.0 × 105 (TCID50/mL)undetectable2 h[17]
Bovine coronavirus
Peroxo titanium acid (70%) + peroxo-modified anataseHokkaido/9/034.4 ± 0.3 log10 (TCID50/0.1 mL)1.6 ± 0.1 log10 (TCID50/0.1 mL)4 h[19]
Table
Table 2. Detailed conditions for each photocatalysis type.
Table 2. Detailed conditions for each photocatalysis type.
PhotocatalystsAgentReactor VolumepH during ReactionTemperaturePhotocatalyst Retained MaterialLightReference
Influenza
TiO2/Black LightH1N1100 µLPBS25 °Csprayed to glass with 1 g TiO2 to 300 m2UV (352 nm)[20]
Pt-WO3H1N1100 µLPBS25 °Ccoated glass *visible light (410–470 nm)[28]
SARS-CoV-2
WO3JPN/TY/WK-52130 µL6.8 (MEM) + 2% FBS20 °C4 g/m2 mixed with silica bindervisible light (>380 nm)[29]
TiO2/LEDJPN/TY/WK-5211 mL6.8 (MEM) + 5% FBS20 °Csprayed to glass fiber sheet **UV (405 nm LED)[17]
Bovine coronavirus
Peroxo titanium acid (70%) + peroxo-modified anataseHokkaido/9/03150 µLPBS25 °C0.2 mg/m2 sprayed to projector filmvisible light (>410 nm)[19]
FBS, fetal bovine serum; MEM, minimal essential medium; PBS, phosphate-buffered saline. * ILUMIO, produced by Sumitomo Chemical Co., Tokyo, Japan, ** produced by Kaltech Co. Ltd., Osaka, Japan. Detailed materials and methods are shown in each reference. The performance of the photocatalytic materials was considered effective when the antiviral activity of a photocatalyst with visible light irradiation (VL) was ≥2.0 and the effect of visible light irradiation (∆V) was ≥0.3, based on the criteria of the Photocatalysis Industry Association of Japan [19,30]. VL of 2.0 and ∆V of 0.3 correspond to mean reductions of 1/100 and 1/2 of viruses, respectively, with visible light irradiation.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Onodera, T.; Sugiura, K.; Haritani, M.; Suzuki, T.; Imamura, M.; Iwamaru, Y.; Ano, Y.; Nakayama, H.; Sakudo, A. Photocatalytic Inactivation of Viruses and Prions: Multilevel Approach with Other Disinfectants. Appl. Microbiol. 2022, 2, 701-715. https://doi.org/10.3390/applmicrobiol2040054

AMA Style

Onodera T, Sugiura K, Haritani M, Suzuki T, Imamura M, Iwamaru Y, Ano Y, Nakayama H, Sakudo A. Photocatalytic Inactivation of Viruses and Prions: Multilevel Approach with Other Disinfectants. Applied Microbiology. 2022; 2(4):701-715. https://doi.org/10.3390/applmicrobiol2040054

Chicago/Turabian Style

Onodera, Takashi, Katsuaki Sugiura, Makoto Haritani, Tohru Suzuki, Morikazu Imamura, Yoshifumi Iwamaru, Yasuhisa Ano, Hiroyuki Nakayama, and Akikazu Sakudo. 2022. "Photocatalytic Inactivation of Viruses and Prions: Multilevel Approach with Other Disinfectants" Applied Microbiology 2, no. 4: 701-715. https://doi.org/10.3390/applmicrobiol2040054

Article Metrics

Back to TopTop